U.S. tariff advisory for Antwerp-based chemical, plastics and pharma exporters. 232 derivatives, AD/CVD, BIS controls.
U.S. tariff advisory for Italian fashion, wine, food and machinery exporters. Reciprocal tariff, luxury valuation, 232 machinery.
U.S. tariff advisory for Frankfurt-based German pharma, precision and finance-sector exporters. Air cargo HTS, 232 pharma.
U.S. tariff advisory for Irish pharma, MedTech and whiskey exporters. Section 232 pharma, 232 MedTech probe, reciprocal tariff.
U.S. tariff advisory for German finished-vehicle and wind-turbine exporters via Bremerhaven. Section 232 auto, wind AD/CVD.
U.S. tariff advisory for Stuttgart-based Mercedes, Porsche, and Tier 1 supplier exporters. Section 232 auto, EV content.
U.S. tariff advisory for Spanish fashion, olive oil, wine and pharma exporters. Reciprocal tariff, AD/CVD, 232 pharma.
U.S. tariff advisory for Polish furniture, auto parts and machinery exporters. Reciprocal tariff, AD, origin documentation.
U.S. tariff advisory for Danish pharma, medtech and dairy exporters. 232 pharma, 232 MedTech probe, reciprocal tariff.
Introduction: Billions in Savings, Mostly Unclaimed The United States currently maintains free trade agreements with 20 countries, each offering reduced or zero-duty rates for goods that meet the agreement’s rules of origin. Collectively, these agreements offer importers access to duty savings that can completely eliminate the tariff burden. And yet, a substantial portion of eligible…